Catalyst Event

Samsung Biologics Co Ltd (207940) · Other

From Akros K-Manufacturing 50 Index (AKMNF50)

3/20/2026, 12:00:00 AM

OtherSentiment: Neutral

At the 15th annual general meeting of shareholders on March 20, 2026, the reappointment of CEO John Rim was approved. Low importance as routine management stability usually results in <5% price impact.

Korean Translation

2026년 3월 20일, 제15기 정기 주주총회에서 대표이사 재선임 안건 가결. 경영 안정성 확보는 긍정적이나 주가 영향은 5% 미만으로 예상됨.

Related Recent Events

View Full Timeline